initial public offerings (IPOs) trading on American exchanges

Tuesday, April 28, 2020

-=Kura Oncology (KURA) :

Rises to its highest levels since December on above 9x average volume, posting gains alongside its peer in the cancer treatments development space, Syndax Pharmaceuticals (SNDX); co's pipeline includes a menin-MLL inhibitor, KO-539.

  • Sector: Healthcare
  • Industry: Biotechnology
  • Full Time Employees: 57
  • Founded in 2014 
  • HQ inSan Diego, California

No comments:

Post a Comment